| Literature DB >> 14698151 |
Brian Dymock1, Xavier Barril, Mandy Beswick, Adam Collier, Nicholas Davies, Martin Drysdale, Alexandra Fink, Christophe Fromont, Roderick E Hubbard, Andrew Massey, Allan Surgenor, Lisa Wright.
Abstract
Multiple co-crystal structures of an adenine-based series of inhibitors bound to the molecular chaperone Hsp90 have been determined. These structures explain the observed SAR for previously described compounds and new compounds, which possess up to 8-fold improved potency against the isolated enzyme. Anti-tumour cell potency and mechanism of action data is also described for the most potent compounds. These data should enable the design of more potent Hsp90 inhibitors.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14698151 DOI: 10.1016/j.bmcl.2003.11.011
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823